Further analysis showed a decreasing trend of HLA-DR− CD3+ T cells and CD4+ T cells in preoperative patients with early NSCLC (Figures 1F, G and Supplementary Figures 1E, F). The gene discussed is CD4; the disease is non-small cell lung carcinoma.